1. Buller HR Destors JM Gallus AS Prins MH Raskob GE Idrabiotaparinux, a biotinylated long-acting anticoagulant, in the treatment of deep venous thrombosis (EQUINOX Study): safety, efficacy, and reversibility by avidin [Abstract No. 32] Blood 2009 18
2. Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis;Equinox Investigators;Journal of Thrombosis and Haemostasis,2011
3. NCT00311090 Bioequipotency study of SSR126517E and idraparinux in patients with deep venous thrombosis of the lower limbs (EQUINOX) clinicaltrials.gov/ct2/show/NCT00311090
4. A multicentre, randomized, double-blind study comparing the efficacy and safety of once daily (o.d.) Org31540/SR90107A versus twice daily (b.i.d.) enoxaparin in the initial treatment of acute symptomatic deep vein thrombosis (DVT) (MATISSE-DVT). Study No: EFC2441 GlaxoSmithKline Clinical Trial Register 2005
5. Buller H Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra): The MATISSE trials Journal of Thrombosis and Haemostasis 2005 Abstract number: P1112